Clinical Trial Update: Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing naltrexone-bupropion to placebo-bupropion for weight loss in individuals with schizophrenia has been terminated; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Schizophrenia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Naltrexone/Bupropion (Naltrexone and bupropion)

Snippet

Sponsor: Yale University | Conditions: Schizophrenia, Diabetes Mellitus, Type 2 | Phase 2 | Status: TERMINATED | Results posted: 2019-08-07